Brief: Astellas Pharma Inc - FDA Grants Priority Review For Sbla Of Padcev With Keytruda For First-Line Treatment Of Advanced Bladder Cancer
30/11/2023 23:31
Dec 1 (Reuters) - Astellas Pharma Inc 4503.T :
* ASTELLAS PHARMA INC: FDA GRANTS PRIORITY REVIEW FOR SBLA
OF
PADCEV WITH KEYTRUDA FOR FIRST-LINE TREATMENT OF ADVANCED
BLADDER CANCER
Source text for Eikon: ID:nTSwd91e5a
Further company coverage: 4503.T
(Reporting by Tokyo Newsroom)
((+81345201189;))